These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29120401)

  • 1. Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
    Guadagni S; Fiorentini G; Clementi M; Palumbo G; Palumbo P; Chiominto A; Baldoni S; Masedu F; Valenti M; Tommaso AD; Fabi B; Aliberti C; Sarti D; Guadagni V; Pellegrini C
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29120401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melphalan hypoxic perfusion with hemofiltration for melanoma locoregional metastases in the pelvis.
    Guadagni S; Fiorentini G; Clementi M; Palumbo G; Chiominto A; Cappelli S; Masedu F; Valenti M
    J Surg Res; 2017 Jul; 215():114-124. PubMed ID: 28688635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.
    Guadagni S; Fiorentini G; Clementi M; Palumbo G; Masedu F; Deraco M; De Manzoni G; Chiominto A; Valenti M; Pellegrini C
    Melanoma Res; 2017 Oct; 27(5):439-447. PubMed ID: 28486243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability.
    Guadagni S; Palumbo G; Fiorentini G; Clementi M; Marsili L; Giordano AV; Masedu F; Valenti M
    BMC Res Notes; 2017 Aug; 10(1):411. PubMed ID: 28810925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced Wild-Type BRAF Melanoma Patients.
    Guadagni S; Zoras O; Fiorentini G; Masedu F; Lasithiotakis K; Sarti D; Farina AR; Mackay AR; Clementi M
    J Surg Res; 2021 Dec; 268():737-747. PubMed ID: 34253376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial.
    van Ijken MG; van Etten B; Guetens G; de Bruijn EA; Ten Hagen TL; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):897-904. PubMed ID: 16084053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
    van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Madu MF; Deken MM; van der Hage JA; Jóźwiak K; Wouters MWJM; van Akkooi ACJ
    Ann Surg Oncol; 2017 Jul; 24(7):1997-2005. PubMed ID: 28188500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot study.
    Guadagni S; Santinami M; Patuzzo R; Pilati PL; Miotto D; Deraco M; Rossi CR; Fiorentini G; Di Filippo F; Valenti M; Amicucci G
    Melanoma Res; 2003 Feb; 13(1):51-8. PubMed ID: 12569285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases.
    Pace M; Gattai R; Mascitelli EM; Millanta L
    J Surg Oncol; 2011 Dec; 104(7):718-23. PubMed ID: 21721008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
    Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
    J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-centre prospective study of isolated limb perfusion with melphalan in the treatment of subungual malignant melanoma.
    Lingam MK; McKay AJ; Mackie RM; Aitchison T
    Br J Surg; 1995 Oct; 82(10):1343-5. PubMed ID: 7489159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated limb perfusion for in-transit melanoma metastases: melphalan or TNF-melphalan perfusion?
    Hoekstra HJ; Veerman K; van Ginkel RJ
    J Surg Oncol; 2014 Mar; 109(4):338-47. PubMed ID: 24403098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermic pelvic perfusion with tumor necrosis factor-α for locally advanced cancers: encouraging results of a phase II study.
    Bonvalot S; de Baere T; Mendiboure J; Paci A; Farace F; Drouard-Troalen L; Bonnet L; Hakime A; Bonniaud G; Raynard B; Israel P; Le Cesne A; Eggermont AM; Laplanche A; Muret J
    Ann Surg; 2012 Feb; 255(2):281-6. PubMed ID: 22241290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four times repeated isolated limb infusion with melphalan-controlled locoregional disease in the patient with melanoma of the leg.
    El Halabi H; Hijaz F; Gushchin V
    Am Surg; 2012 Dec; 78(12):E504-5. PubMed ID: 23265100
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeat isolated limb perfusion with TNFalpha and melphalan for recurrent limb melanoma after failure of previous perfusion.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Geel AN; Eggermont AM; Kroon BB
    Eur J Surg Oncol; 2006 Apr; 32(3):318-24. PubMed ID: 16412605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanoma.
    Guadagni S; Russo F; Rossi CR; Pilati PL; Miotto D; Fiorentini G; Deraco M; Santinami M; Palumbo G; Valenti M; Amicucci G
    Am J Surg; 2002 Jan; 183(1):28-36. PubMed ID: 11869699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit.
    Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P
    Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated pelvic perfusion in irradiated unresectable recurrence of pelvic tumor: preliminary outcome and ongoing study.
    Uzan C; Goere D; Dumont F; Gouy S; Muret J; Hakime A; De Baere T; Bonvalot S
    J Visc Surg; 2014 Apr; 151 Suppl 1():S11-5. PubMed ID: 24582274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.